SUPERNUS PHARMACEUTICALS, INC.·4

Feb 20, 4:44 PM ET

Barlow Carrolee 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Supernus (SUPN) Director Carrolee Receives RSU Award

What Happened
Director Carrolee received two restricted stock unit (RSU) awards from Supernus on February 18, 2026: 2,989 RSUs and 4,977 RSUs, for a total of 7,966 RSUs. Each unit was reported at $0.00 at grant (total reported acquisition value $0). These are compensation awards (transaction code A), not open‑market purchases or sales.

Key Details

  • Transaction date: February 18, 2026; filing date: February 20, 2026 (filed within the Form 4 reporting window).
  • Grant amounts/prices: 2,989 RSUs @ $0.00 and 4,977 RSUs @ $0.00 (total 7,966 RSUs).
  • Vesting/settlement: Footnotes state each RSU equals one share (F1) and the RSUs will be settled in common stock upon vesting on February 18, 2027 (F2).
  • Shares owned after transaction: not disclosed in this filing.
  • Transaction code: A = award/grant; these are derivative equity awards (RSUs), not immediate share purchases or sales.
  • Filing timeliness: appears timely (filed two days after the grant).

Context
RSUs are a form of equity compensation that convert to shares upon vesting; no cash changed hands at grant and the award does not represent an immediate buy or sell in the market. Such grants are common for directors and reflect compensation arrangements rather than a direct signal to buy or sell the stock. (A separate footnote in the filing notes options vesting on the same date, but the reported transactions here are RSU awards.)

Insider Transaction Report

Form 4
Period: 2026-02-18
Transactions
  • Award

    Restricted Stock Unit

    [F1][F2]
    2026-02-18+2,9892,989 total
    Common Stock (2,989 underlying)
  • Award

    Director Stock Option (Right to Buy)

    [F3]
    2026-02-18+4,9774,977 total
    Exercise: $50.20Exp: 2036-02-18Common Stock (4,977 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
  • [F2]These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027.
  • [F3]Each option vests on February 18, 2027.
Signature
/s/ Timothy C. Dec, as attorney-in-fact|2026-02-20

Documents

1 file
  • 4
    wk-form4_1771623865.xmlPrimary

    FORM 4